(Q82294671)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22044687%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Decreased xanthine oxidoreductase (XOR) is associated with a worse prognosis in patients with serous ovarian carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22044687%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22044687%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Heini Lassus

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22044687%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Ralf Bützow

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22044687%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Mikael Lundin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22044687%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Johan Lundin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22044687%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

29 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22044687%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22044687%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

124

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22044687%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22044687%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

311-318

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22044687%20AND%20SRC:MED&resulttype=core&format=json

Identification of proteins binding to E-Box/Ku86 sites and function of the tumor suppressor SAFB1 in transcriptional regulation of the human xanthine oxidoreductase gene

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.026

The housekeeping gene xanthine oxidoreductase is necessary for milk fat droplet enveloping and secretion: gene sharing in the lactating mammary gland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.026

Xanthine oxidase in eutopic and ectopic endometrium in endometriosis and adenomyosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.026

Mammalian molybdo-flavoenzymes, an expanding family of proteins: structure, genetics, regulation, function and pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.026

Migratory activity of human breast cancer cells is modulated by differential expression of xanthine oxidoreductase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.026

Posttranslational inactivation of human xanthine oxidoreductase by oxygen under standard cell culture conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.026

Hypoxia injures endothelial cells by increasing endogenous xanthine oxidase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.026

Xanthine oxidoreductase promotes the inflammatory state of mononuclear phagocytes through effects on chemokine expression, peroxisome proliferator-activated receptor-{gamma} sumoylation, and HIF-1{alpha}

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.026

Molecular cloning of a cDNA coding for mouse liver xanthine dehydrogenase. Regulation of its transcript by interferons in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.026

Down-regulated xanthine oxidoreductase is a feature of aggressive breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.026

Xanthine oxidoreductase - clinical significance in colorectal cancer and in vitro expression of the protein in human colon cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.026

Decreased xanthine oxidoreductase is a predictor of poor prognosis in early-stage gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.026

Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.026

Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.026

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.026

Clinical practice. Screening for ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.026

Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.026

Reporting results of cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.026

Comparison of standard and CA-125 response criteria in patients with epithelial ovarian cancer treated with platinum or paclitaxel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.026

Tissue microarrays for high-throughput molecular profiling of tumor specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.026

Distinct subtypes of serous ovarian carcinoma identified by p53 determination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.026

ERBB2 amplification is superior to protein expression status in predicting patient outcome in serous ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.026

Mouse mammary gland xanthine oxidoreductase: purification, characterization, and regulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.026

Functional regulation of xanthine oxidoreductase expression and localization in the mouse mammary gland: evidence of a role in lipid secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.026

Key stages in mammary gland development. Secretory activation in the mammary gland: it's not just about milk protein synthesis!

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.026

10.1016/J.YGYNO.2011.10.026

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22044687%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference